International Journal of Radiation Oncology*Biology*Physics · 2018 · 123 citations · 30 references
Dose-escalated prostate SBRT was administered with minimal toxicity in this multi-institutional study. Relapse rates compared favorably with historical controls. SBRT is a suitable option for LR and IR prostate cancer.
30